IGF1 and Ewing sarcoma: Despite the limitation with material quality, the informative and high quality material lead to the identification of biomarker heterogeneity between each cell of a Ewing tumour core biopsy, including in the commonly assayed signalling pathways frequently deranged in these tumours, namely the MAPK and IGF-PI3K pathways.